390 related articles for article (PubMed ID: 6180206)
21. Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen.
Ziai MR; Imberti L; Nicotra MR; Badaracco G; Segatto O; Natali PG; Ferrone S
Cancer Res; 1987 May; 47(9):2474-80. PubMed ID: 3552215
[TBL] [Abstract][Full Text] [Related]
22. Differential Ia antigen expression by autologous human erythroid and B lymphoblastoid cell lines.
Symington FW; Levine F; Braun M; Brown SL; Erlich HA; Torok-Storb B
J Immunol; 1985 Aug; 135(2):1026-32. PubMed ID: 3874223
[TBL] [Abstract][Full Text] [Related]
23. Specificity of monoclonal antibodies to an EBV transformed B-cell line.
Schröder J; Suomalainen HA; Parkkinen E; Lundqvist C; Wada G; Koskimies S
Med Biol; 1982 Oct; 60(5):255-9. PubMed ID: 6296556
[TBL] [Abstract][Full Text] [Related]
24. The role of three distinct Ia-like antigen molecules in human T cell proliferative responses: effect of monoclonal anti-Ia-like antibodies.
Koide Y; Awashima F; Yoshida TO; Takenouchi T; Wakisaka A; Moriuchi J; Aizawa M
J Immunol; 1982 Sep; 129(3):1061-9. PubMed ID: 6179989
[TBL] [Abstract][Full Text] [Related]
25. IA mutant functional antigen-presenting cell lines.
Glimcher LH; Hamano T; Asofsky R; Sachs DH; Pierres M; Samelson LE; Sharrow SO; Paul WE
J Immunol; 1983 May; 130(5):2287-94. PubMed ID: 6300242
[TBL] [Abstract][Full Text] [Related]
26. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
27. Structural heterogeneity of the human Ia molecular pool as detected by cross-reacting mouse monoclonal antibodies.
Accolla RS; Pierres M
J Immunol; 1983 Jan; 130(1):283-8. PubMed ID: 6183351
[TBL] [Abstract][Full Text] [Related]
28. Recognition of HLA-A2 mutant and variant target cells by an HLA-A2 allospecific human cytotoxic T lymphocyte line.
Ware CF; Krangel MS; Pious D; Burakoff SJ; Strominger JL
J Immunol; 1983 Sep; 131(3):1312-7. PubMed ID: 6193184
[TBL] [Abstract][Full Text] [Related]
29. Immunochemical analysis of the Ia polymorphisms among the family of DR7-associated HLA-D specificities.
Karr RW
J Immunol; 1986 Feb; 136(3):999-1006. PubMed ID: 3510255
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibodies against cell surface antigens present on human urinary bladder cancer cells.
Masuko T; Yagita H; Hashimoto Y
J Natl Cancer Inst; 1984 Mar; 72(3):523-30. PubMed ID: 6583438
[TBL] [Abstract][Full Text] [Related]
31. OKT4+ cytotoxic T cells can lyse targets via class I molecules and can be blocked by monoclonal antibody against T4 molecules.
Strassman G; Bach FH
J Immunol; 1984 Oct; 133(4):1705-9. PubMed ID: 6332131
[TBL] [Abstract][Full Text] [Related]
32. Mouse monoclonal antibodies against rat major histocompatibility antigens. Two Ia antigens and expression of Ia and class I antigens in rat thymus.
Fukumoto T; McMaster WR; Williams AF
Eur J Immunol; 1982 Mar; 12(3):237-43. PubMed ID: 6178598
[TBL] [Abstract][Full Text] [Related]
33. The T cell response to allelic determinants on Igh-1-encoded IgG2a antibodies: dual recognition examined by using antigenic antibodies with binding affinity for Ia molecules.
Hedrick SM; Schwartz RH
J Immunol; 1983 Apr; 130(4):1958-66. PubMed ID: 6187829
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibodies to polymorphic epitopes on Ia antigens: three independent groups of determinants expressed on DRw6 homozygous cells.
Johnson JP; Wank R
Eur J Immunol; 1984 Aug; 14(8):739-44. PubMed ID: 6205884
[TBL] [Abstract][Full Text] [Related]
35. Analysis of HLA-DR antigens by using monoclonal antibodies: recognition of conformational differences in biosynthetic intermediates.
Shackelford DA; Lampson LA; Strominger JL
J Immunol; 1981 Oct; 127(4):1403-10. PubMed ID: 6944380
[TBL] [Abstract][Full Text] [Related]
36. Biochemical and immunologic heterogeneity of Ia glycoproteins isolated from a chronic lymphocytic leukemia.
Letarte M; Falk J
J Immunol; 1982 Jan; 128(1):217-23. PubMed ID: 6976373
[TBL] [Abstract][Full Text] [Related]
37. Human Ia-like antigens (Analysis of the tissue distribution and immunochemical profile with monoclonal antibodies).
Natali PG; Russo C; Apollonj C; Pellegrino MA; Ferrone S
Ric Clin Lab; 1981; 11(4):287-300. PubMed ID: 7034133
[TBL] [Abstract][Full Text] [Related]
38. The analysis with monoclonal antibodies of the heterogeneity of Ia glycoproteins on chronic lymphocytic leukemia cells.
Addis JB; Tisch R; Falk JA; Letarte M
J Immunol; 1982 Nov; 129(5):2033-9. PubMed ID: 6181156
[TBL] [Abstract][Full Text] [Related]
39. Immunologic characterization and molecular profile of carcinoembryonic antigen detected by monoclonal antibodies.
Imai K; Moriya Y; Fujita H; Tsujisaki M; Kawaharada M; Yachi A
J Immunol; 1984 Jun; 132(6):2992-7. PubMed ID: 6202769
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneity of the induction of HLA-DR expression by human immune interferon on glioma cell lines and their clones.
Piguet V; Carrel S; Diserens AC; Mach JP; de Tribolet N
J Natl Cancer Inst; 1986 Feb; 76(2):223-8. PubMed ID: 3080635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
